SUTANTATUG ENVEDOTIN
UNII STG683M7KV

Substance Identification & Data

This profile provides standardized clinical and technical data for Sutantatug Envedotin, uniquely identified by the FDA Unique Ingredient Identifier (UNII) STG683M7KV.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 3049680-25-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

STG683M7KV

CAS Registry Number

3049680-25-0

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

SUTANTATUG ENVEDOTIN

Official standardized name for this substance within the FDA UNII nomenclature system.

INN ID

13839

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

Sutantatug Envedotin

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Sutantatug Envedotin. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

Sutantatug Envedotin

Common Names & Synonyms

H-gamma1 heavy chain humanized (1-446) [VH (Homo sapiens IGHV1-3*01 (89.8%) -(IGHD) -IGHJ4*01 (100%), CDR-IMGT [8.8.9] (26-33.51-58.97-105)) (1-116) -Homo sapiens IGHG1*03 (100%) G1m3, nG1m1 CH1 R120, CH3 E12, M14 (CH1 R120 (213) (117-214), hinge 1-15 (215-229), CH2 (230-339), CH3 E12 (355), M14 (357) (340-444), CHS (445-446)) (117-446)], (219-214')-disulfide with L-kappa light chain humanized (1'-214') [V-KAPPA (Homo sapiens IGKV1-6*01 (84.2%) -IGKJ4*01 (91.7%), CDR-IMGT [6.3.9] (27'-32'.50'-52'.89'-97')) (1'-107') -Homo sapiens IGKC*01 (100%) Km3 A45.1, V101 (C-KAPPA A45.1 (153'), V101 (191')) (108'-214')]; dimer (225-225'':228-228'')-bisdisulfide, produced in Chinese hamster ovary (CHO) cells, cell line CHO-K1SV, lacking the glutamine synthetase (GS-KO) gene, glycoform alfa; substituted at the side chain nitrogen atom of an average of two L-glutaminyl residues among 294 and 294'' with (6S,9S)-1-amino-6-({4-[(5S,8S,11S,12R)-11-[(2S)-butan-2-yl]-12-(2-{(2S)-2-[(1R,2R)-3-{[(1S,2R)-1-hydroxy-1-phenylpropan-2-yl]amino}-1-methoxy-2-methyl-3-oxopropyl]pyrrolidin-1-yl}-2-oxoethyl)-4,10-dimethyl-3,6,9-trioxo-5,8-di(propan-2-yl)-2,13-dioxa-4,7,10-triazatetradecan-1-yl]phenyl}carbamoyl)-1,8,11-trioxo-9-(propan-2-yl)-13,16,19-trioxa-2,7,10-triazahenicosan-21-yl (envedotin) groups

Immunoglobulin G1, anti-(human nectin 4) (human-Mus musculus monoclonal SYS6002 γ1-chain), disulfide with human-Mus musculus monoclonal SYS6002 κ-chain, dimer, 294,294′-diamide with N-[[[4-[[N-[2-[2-[2-(2-aminoethoxy)ethoxy]ethoxy]acetyl]-L-valyl-N5-(aminocarbonyl)-L-ornithyl]amino]phenyl]methoxy]carbonyl]-N-methyl-L-valyl-N-[(1S,2R)-4-[(2S)-2-[(1R,2R)-3-[[(1R,2S)-2-hydroxy-1-methyl-2-phenylethyl]amino]-1-methoxy-2-methyl-3-oxopropyl]-1-pyrrolidinyl]-2-methoxy-1-[(1S)-1-methylpropyl]-4-oxobutyl]-N-methyl-L-valinamide

immunoglobulin G1-kappa, anti-[Homo sapiens NECTIN4 (nectin-4, nectin cell adhesion molecule 4, PVRL4, poliovirus receptor-related 4, PPR4, LNIR)], humanized monoclonal antibody, conjugated on an average of two glutaminyl residues to envedotin, comprising a cleavable linker and monomethylauristatin E (MMAE) (sutantatug envedotin)

sutantatug envedotin [INN]

External Clinical & Regulatory Resources

Previous UNIISTG4R49RUU

Next UNIISTH48RN3QL